Pharmacogenomics and Drug Metabolism
Articles
Lyman, S.D., Poland, A., and
Taylor, B.A. Genetic polymorphism of microsomal epoxide
hydrolase activity in the mouse. J. Biol. Chem. 255,
8650-8654, 1980.
Lyman,
S.D., and Poland, A.
Effect of the brachymorphic trait in mice on xenobiotic
sulfate ester formation. Biochem. Pharm. 32, 3345-3350,
1983.
Jordan,
V.C., Bain, R.R.,
Lyman, S.D., and Brown, R.R.
Analysis of Tamoxifen and its metabolites. In:
Drug
Determination in Therapeutic and Forensic
Context, Ed. by E. Reid
and I.D. Wilson, Plenum Press, p. 219-225, 1984.
Lyman,
S.D., and Jordan, V.C.
Antiestrogenic effect of trifluoperazine in mice. Biochem.
Pharmacol. 34, 2221-2224, 1985.
Lyman,
S.D., and Jordan, V.C.
Metabolism of Tamoxifen and its uterotrophic activity.
Biochem. Pharmacol. 34, 2787-2794, 1985.
Lyman,
S.D., and Jordan, V.C.
Possible mechanisms for the agonist actions of Tamoxifen
and the antagonist actions of MER-25 (Ethamoxytriphetol) in
the mouse uterus. Biochem. Pharmacol. 34, 2795-2806, 1985.
Jordan,
V.C., Tate, A.C.,
Lyman, S.D., Gosden, B., Wolf,
M.F., Bain, R.R., and Welshons, W.V. Rat uterine growth and
induction of progesterone receptor without estrogen
receptor translocation. Endocrinology 116, 1845-1857, 1985.
Lyman,
S.D., and Jordan, V.C.
Metabolism of non-steroidal antiestrogens, In:
Estrogen and
Antiestrogen Action (V.C. Jordan, Ed.),
University of Wisconsin Press, Madison, WI, pp. 191-219,
1986.
